Hyderabad, Feb. 18 -- At BioAsia 2026, "TechBio Unleashed: AI, Automation and the Biology Revolution", a homegrown deep-tech startup emerged as a powerful example of India's growing biotech strength. Dr Jagan Mohan Reddy, Founder and CEO of BioVaram (officially known as UR Advanced Therapeutics), unveiled a pioneering innovation that blends artificial intelligence with regenerative medicine to reshape the future of therapeutic research.

Founded in 2020, with formal operations beginning in 2022, BioVaram focuses on tissue engineering and regenerative medicine. The company is developing AI-integrated peptides as alternatives to extracellular matrix (ECM) proteins, the essential "cement" that holds cells together in the human body. Just as ...